Fig. 4From: Synergism of wt-p53 and synthetic material in local nano-TAE gene therapy of hepatoma: comparison of four systems and the possible mechanismVX2 tumor can be shown clearly by CT on the left lobe of liver (T, area showed by white cross) before emulsion injection. After in vivo intra-arterial injection of PEGFP-C2-wt-P53/lipiodol (A), L-nanoplex/lipiodol (E), U-nanoplex/lipiodol (B), Ca-nanoplexCa-nanoplex/lipiodol (C), Pll-nanoplex/lipiodol (D), nanoplex emulsion in group D displayed significantly stronger and more selectively deposits in tumor area (D, area showed by black cross), compared to the slight but selective deposits in group B (B, area showed by black cross), whereas emulsions in group A, C, E produced no tumor-selective retention potency but diffuse distribution in liver. In contrast to group A, B, C and E, EGFP-wt-P53 expression was observed by fluorescence microscope (FM) for green fluorescence (the arrow) and by western blot for a ∼ 72 kDa molecular weight band only in tumor of group DBack to article page